Rocket Lab Is Down 57% From Its Peak While Analysts See 49% Upside. Who Has It Right?

Rocket Lab’s outlook improved sharply as analysts cite fast growth and contracting momentum: Q1 2026 launches hit 31, sales rose 64% to $200M, and the adjusted EBITDA loss narrowed to $11.8M vs a $26M consensus loss. The company also secured $397M and an additional $266M U.S. Space Force contracts to develop/launch/operate advanced flat satellites and complete multiple suborbital launches, while backlog rose 108% to $2.2B. Despite a still-unprofitable $45M net loss and a high 53x price-to-sales multiple, the average analyst price target is $111.31 (+49%).

Analysis

RKLB is increasingly being priced as a defense-enabled infrastructure name rather than a pure launch story. That matters because government work can de-risk revenue visibility and subsidize fixed-cost development, but only if the company keeps delivery risk contained; otherwise the market will eventually treat backlog as option value, not earnings power. In the near term, the setup is more about multiple expansion from credibility than near-term profit acceleration.

The second-order winners are the broader space-defense supply chain and incumbent primes with exposure to proliferated space architectures; the losers are speculative space names that lack either recurring government demand or a credible path to scale. If RKLB proves it can win repeatable contracts and execute on Neutron, it can start taking share of investor attention from higher-burn peers and command a higher quality-adjusted multiple. But if launch cadence slips or contract economics are thin, the stock’s premium sales multiple is vulnerable to sharp compression.

Consensus is probably underestimating how fragile the rerating is. At this valuation, the market is already capitalizing several years of execution, so the next 1-3 month catalyst is not more headline contracts but margin mix, cash burn, and schedule discipline; over 6-18 months, the thesis lives or dies on conversion of backlog into free cash flow. A single delay in Neutron or a step-up in dilution would be enough to break the bullish narrative.

Key Decisions for Investors

• Tactically long RKLB only on pullbacks or post-event consolidation; express it via a 3-6 month call spread to cap valuation risk and avoid paying full implied volatility.
• Pair trade: long RKLB / short a basket of higher-beta, less-proven space names or the space theme ETF if sentiment keeps expanding faster than fundamentals; this isolates the quality-of-revenue re-rating.
• Set a hard risk trigger: exit or hedge if Neutron timing slips, quarterly cash burn worsens materially, or adjusted EBITDA losses stop narrowing for two consecutive quarters.
• If the stock continues to rerate, take profits into strength rather than chasing; the thesis is execution-led, and a miss would likely cause a sharper de-rating than the upside from another contract announcement.